Adrenocortical carcinoma secreting cortisol, androgens and aldosterone: A case report

Cases Journal

Volumn 2, Issue 9, 2009, Pages

  Peppa, Melpomeni ^a   Pikounis, Vasilios ^a   Papaxoinis, Georgios ^a   Macheras, Anastasios ^a   Economopoulos, Theofanis ^a   Raptis, Sotirios A ^a,b   Hadjidakis, Dimitrios ^a  

^a UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

^b Hellenic National Diabetes Center   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

MITOTANE; SPIRONOLACTONE;

ADRENAL CORTEX ADENOMA; ADRENAL CORTEX CARCINOMA; ADRENALECTOMY; ADULT; ALDOSTERONE RELEASE; ANDROGEN RELEASE; ARTICLE; CANCER CHEMOTHERAPY; CANCER SURVIVAL; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; FEMALE; HIRSUTISM; HORMONE RELEASE; HUMAN; HYDROCORTISONE RELEASE; HYPERALDOSTERONISM; HYPERANDROGENISM; HYPERCORTISOLISM; HYPERNATREMIA; HYPERTENSION; HYPOKALEMIA; LIVER METASTASIS; LIVER RESECTION; QUALITY OF LIFE; TUMOR RECURRENCE; VAGINA BLEEDING;

EID: 77953365094     PISSN: 17571626     EISSN: None     Source Type: Journal    
DOI: 10.4076/1757-1626-2-8951     Document Type: Article

References (8)

1. Stojadinovic A, Ghossein RA, Hoos A, Nissan A, Marshall D, Dudas M, Cordon-Cardo C, Jaques DP, Brennan MF: Adrenocortical carcinoma: clinical, morphologic, and molecular characterization. J Clin Oncol 2002, 20:941-950.
2. Schulik RD, Brennan MF: Long-term survival after complete resection and repeat resection in patients with adrenocortical carcinoma. Annals Surg Oncol 1999, 6:719-726.
3. Abiven G, Coste J, Groussin L, Anract P, Tissier F, Legmann P, Dousset B, Bertagna X, Bertherat J: Clinical and biological features in the prognosis of adrenocortical cancer: poor outcome of cortisol-secreting tumors in a series of 202 consecutive patients. JCEM 2006, 91:2650-2656.
4. Icard P, Goudet P, Charpenay C, Andreassian B, Carnaille B, Chapuis Y, Cougard P, Henry JF, Proye C: Adrenocortical carcinomas: surgical trends and results of a 253-patient series from the French Association of Endocrine Surgeons study group. World J Surg 2001, 25:891-897.
5. Kendrick ML, Curlee K, Lloyd R, Farley DR, Grant CS, Thompson GB, Rowland C, Young WF Jr, van Heerden JA: Aldosterone-secreting adrenocortical carcinomas are associated with unique operative risks and outcomes. Surgery 2002, 132:1008-1011.
6. Wajchenberg BL, Albergaria Pereira MA, Medonca BB, Latronico AC, Campos Carneiro P, Alves VA, Zerbini MC, Liberman B, Carlos Gomes G, Kirschner MA: Adrenocortical carcinoma: clinical and laboratory observations. Cancer 2000, 88:711-736.
7. Terzolo M, Angeli A, Fassnacht M, Daffara F, Tauchmanova L, Conton PA, Rossetto R, Buci L, Sperone P, Grossrubatscher E, Reimondo G, Bollito E, Papotti M, Saeger W, Hahner S, Koschker AC, Arvat E, Ambrosi B, Loli P, Lombardi G, Mannelli M, Bruzzi P, Mantero F, Allolio B, Dogliotti L, Berruti A: Adjuvant mitotane treatment for adrenocortical carcinoma. N Engl J Med 2007, 356:2372-2380.
8. Allolio B, Fassnacht M: Clinical review: Adrenocortical carcinoma: clinical update. J Clin Endocrinol Metab 2006, 91:2027-2037.